Pancreatic Cancer Research

ResearcherUniversity of WashingtonNo recent work listed

Joo Ha Hwang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7534-230X; OpenAlex author ID A5066929075; NIH RePORTER profile ID 1951134. Sources: ClinicalTrials.gov.

Their work

Papers
10 (first author 2, last author 4)
Trials
2 (principal investigator on 2)
Grants
1
Labs led
2
Collaborators
21
Papers, trials and grants by year

2008: 1 trial · 2009: none · 2010: none · 2011: 2 papers · 2012: none · 2013: none · 2014: none · 2015: 1 paper · 2016: 1 paper · 2017: 2 papers · 2018: 1 paper · 2019: 1 trial · 2020: 2 papers · 2021: 1 grant · 2022: none · 2023: 1 paper

Papers 10

  1. Chronic effects of pulsed high intensity focused ultrasound aided delivery of gemcitabine in a mouse model of pancreatic cancer. Last author DOI 10.1016/j.ultras.2023.106993↗
  2. Increased tumour burden alters skeletal muscle properties in the KPC mouse model of pancreatic cancer. Co-author DOI 10.1002/rco2.13↗
  3. Magnetic resonance imaging biomarkers for pulsed focused ultrasound treatment of pancreatic ductal adenocarcinoma. Co-author DOI 10.3748/wjg.v26.i9.904↗
  4. Hyperthermia-enhanced targeted drug delivery using magnetic resonance-guided focussed ultrasound: a pre-clinical study in a genetic model of pancreatic cancer. Last author DOI 10.1080/02656736.2017.1336675↗
  5. Focused ultrasound for immuno-adjuvant treatment of pancreatic cancer: An emerging clinical paradigm in the era of personalized oncotherapy. Last author DOI 10.1080/08830185.2017.1363199↗
  6. A meta-analysis of palliative treatment of pancreatic cancer with high intensity focused ultrasound. Co-author DOI 10.1186/s40349-017-0080-4↗
  7. HIFU for Palliative Treatment of Pancreatic Cancer. First author DOI 10.1007/978-3-319-22536-4_5↗
  8. Pulsed High-Intensity Focused Ultrasound Enhances Delivery of Doxorubicin in a Preclinical Model of Pancreatic Cancer. Last author DOI 10.1158/0008-5472.can-15-0296↗
  9. Concurrent chemotherapy and pulsed high-intensity focused ultrasound therapy for the treatment of unresectable pancreatic cancer: initial experiences. Co-author DOI 10.3348/kjr.2011.12.2.176↗
  10. HIFU for palliative treatment of pancreatic cancer. First author DOI 10.3978/j.issn.2078-6891.2011.033↗

Trials 2

  1. Focused Ultrasound for the Treatment of Pancreatic Cancer - an International Registry Principal investigator NCT03724435↗
  2. High Intensity Focused Ultrasound Tumor Treatment for Pancreatic Cancer Pain Principal investigator NCT00637364↗

Grants 1

  1. Ultrasound-enhanced drug penetration for treatment of pancreatic cancer R01CA154451↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tatiana D. Khokhlova · 5 shared papers, 2011–2023 · strength 0.55
  2. Tim Meakem · 1 shared trial, 2019 · strength 0.24
  3. Joan Vidal-Jove · 1 shared trial, 2019 · strength 0.24
  4. Ravneet Vohra · 2 shared papers, 2020 · strength 0.22
  5. Donghoon Lee · 2 shared papers, 2018–2020 · strength 0.19
  6. Ezekiel J. Maloney · 2 shared papers, 2017–2020 · strength 0.17
  7. Amy E. Chang · 2 shared papers, 2015–2018 · strength 0.12
  8. Sunil R. Hingorani · 2 shared papers, 2015–2018 · strength 0.12
  9. Donghoon Lee · 1 shared paper, 2020 · strength 0.11
  10. Alessandro Napoli · 1 shared paper, 2017 · strength 0.07
  11. Pejman Ghanouni · 1 shared paper, 2017 · strength 0.07
  12. Susan Dababou · 1 shared paper, 2017 · strength 0.07
  13. Navid Farr · 1 shared paper, 2018 · strength 0.07
  14. Venu Gopal Pillarisetty · 1 shared paper, 2017 · strength 0.07
  15. Hong Chen · 1 shared paper, 2015 · strength 0.05
  16. Tong Li · 1 shared paper, 2015 · strength 0.05
  17. Joon Koo Han · 1 shared paper, 2011 · strength 0.03
  18. Jae Young Lee · 1 shared paper, 2011 · strength 0.03
  19. Byung Ihn Choi · 1 shared paper, 2011 · strength 0.03
  20. Ji Kon Ryu · 1 shared paper, 2011 · strength 0.03
  21. Yong‐Tae Kim · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.